G. MAINA, G.E. MACCAFERRI, U. ALBERT, F. BOGETTO - Vol. 10, March 2004, Issue 1
Testo Bibliografia Summary Indice
L’ipomania farmacoindotta: una revisione della
letteratura
Drug-induced hypomania: a review of literature
1 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 4th Edition. Text Revision. Washington DC: APA 2000.
2 Akiskal HS, Djenderedjian AH, Rosenthal RH, Khani MK. Cyclothymic disorder: Validating criteria for inclusion in the bipolar affective group. Am J Psychiatry 1977;134:1227-33.
3 Jamison KR, Gerner RH, Hammen C. Clouds and silver linings: positive experiences associated with primary affective disorders. Am J Psychiatry 1980;137:198-202.
4 Akiskal HS, Khani MK, Scott-Strauss A. Cyclothymic temperamental disorders. Psych Clin North Am 1979a;2:527-54.
5 Akiskal HS, Rosenthal TL, Kashgarian M, Khani MK, Puzantian VR. Differentiation of primary affective illness from situational, symptomatic, and secondary depressions. Arch Gen Psychiatry 1979b;36:635-43.
6 Wicki W, Angst J. The Zurich study. X. Hypomania in a 28- to 30-year-old cohort. Eur Arch Psychiatry Clin Neurosci 1991;40:339-48.
7 Angst J. The emerging epidemiology of hypomania bipolar II disorder. J Affective Disord 1998;50:143-51.
8 Bunney WE. Psychopharmacology of the switch process in affective illness. In: Lipton MA, Di Mascio A, Killam KF, ed. Psychopharmacology – a generation of progress. New York: Raven Press 1978.
9 Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972;26:57-63.
10 Akiskal HS, Bourgeois ML, Post R, Moller HJ, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affective Disord 2000;59:S5-S30.
11 Cassano GB, Akiskal HS, Savino M, Musetti L, Perugi G, Soriani A. Proposed subtypes of bipolar II and I disorders: with hypomanic episodes (or cyclothymia) and with hyperthymic temperament. J Affective Disord 1992;26:127-40.
12 Lewinsohn PM, Klein DL, Seeley JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adol Psychiatry 1995;34:454-63.
13 Szadoczky E, Papp ZI, Rihmer Z, Furedi J. The prevalence of major depressive and bipolar disorder in Hungary. J Affective Disord 1998;50:155-62.
14 Benazzi F, Akiskal HS. Delineating bipolar II mixed states in the Ravenna-San Diego collaborative study: the relative prevalence and diagnostic significance of hypomanic features during major depressive episodes. J Affective Disord 2001;67:115-22.
15 Akiskal HS, Walker PW, Puzantian VR, King D, Rosenthal TL, Dranon M. Bipolar outcome in the course of depressive illness. J Affective Disord 1983;5:115-28.
16 Rosenthal TL, Akiskal HS, Scott-Strauss A, Rosenthal RH, David M. Familial and developmental factors in characterological depression. J Affective Disord 1981;3:183-92.
17 Rihmer Z. Dysthymia: a clinician’s perspective. In: Burton SW, Akiskal HS, ed. Dysthymic disorder. Royal College of Psychiatrists, London, Gaskell 1990.
18 Himmelhoch JM. Social anxiety, hypomania and the bipolar spectrum: Data, theory and clinical issues. J Affective Disord 1998;50:203-13.
19 Perugi G, Akiskal HS, Ramacciotti S, Nassini S, Toni C. Depressive comorbidity of panic, social phobic, and obsessive-compulsive disorders re-examined: Is there a bipolar II connection? J Psychiatry Res 1999;33:53-61.
20 Boerlin HL, Gitlin MJ, Zoellner LA, Hammen CL. Bipolar depression and antidepressant-induced mania: a naturalistic study. J Clin Psychiatry 1998;59:374 -9.
21 Peet M. Induction of mania with selective serotonine re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994;164:549-50.
22 Howland RH. Induction of mania with serotonin re-uptake inhibitors. J Clin Psychopharmacol 1996;16:425-7.
23 Montgomery SA. Selective serotonine re-uptake inhibitors in the acute treatment of depression. In: Bloom FE, Kupfer DJ, ed. Psychopharmacology: the fourth generation of progress. New York: Raven press 1995.
24 Preskorn SH. Antidepressant options in primary care. Clinical Cornerstone 1999;1:31-55.
25 Muller-Oerlinghausen B, Bergofer A, Bauer M. Bipolar disorders. Lancet 2002;359:241-7.
26 Stoll AL, Mayer PV, Kolbrener M, Goldstein E, Suplit B, Lucier J, et al. Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am J Psychiatry 1994;151:1642-5.
27 Amsterdam JD, Garcia-Espana F. Venlafaxine monotherapy in women with bipolar II and unipolar major depression. J Affective Disord 2000;59:225-9.
28 Smith D, Dempster C, Glanville J, Freemantle N, Anderson I. Efficacy and tolerability of venlafaxine compared with selective serotonin re-uptake inhibitors and other antidepressant: a meta-analysis. Br J Psychiatry 2002;180:396-404.
29 Maina G, Ceregato A, Forner F, Maccaferri GE, Rosso G, Bogetto F. Ipomania farmacoindotta e trattamenti antidepressivi con inibitori selettivi del re-uptake. Minerva Psichiatrica 2003;44:69-74.